A world-renowned expert on tailbone pain, Patrick M. Foye, M.D., has been named a contributor to MerckManuals.com, an authoritative digital medical reference.
His online chapter is titled Coccyx Disorders, more commonly known as tailbone
disorders.
Dr. Foye is a Professor of Physical Medicine and Rehabilitation at Rutgers
New Jersey Medical School, in Newark, where he is Founder and Director
of the Tailbone Pain Center.
He is a graduate of Rutgers New Jersey Medical School and did his
residency at Northwestern University's Rehabilitation Institute of Chicago.
Dr. Foye joins a team of more than 350 specialists who contribute to the
website: all content is reviewed by an independent editorial board and
regularly updated online.
More about MerckManuals.com
Visitors to www.MerckManuals.com can choose between advanced content
designed for healthcare professionals and medical students, or easier to
understand material tailored to patients and consumers, all from the same
authoritative resource.
Users of the multi-media website will find an ever expanding online
collection of assets, including a news feed, commentary, infographics,
videos, podcasts, 3D models, as well as health calculators and trackers.
Provided as a public service by Merck & Co., Inc., access to the website is
unlimited and always free, there is no registration, and visitors are never
asked to provide personal information. The user experience is not
compromised by advertising or sponsored content of any kind.
The digital offering, available in 14 languages, is the most current version
of the subject matter contained in The Merck Manuals, a series of medical
reference books long trusted by doctors and patients alike.
First published in 1899, The Merck Manual for professionals is now in its
20th edition. The first edition of the consumer version of the book was
introduced in 1997.
Merck
At Merck, known as MSD outside of the United States and Canada, we are
unified around our purpose: We use the power of leading-edge science to
save and improve lives around the world. For more than 130 years, we
have brought hope to humanity through the development of important
medicines and vaccines. We aspire to be the premier research-intensive
biopharmaceutical company in the world – and today, we are at the
forefront of research to deliver innovative health solutions that advance the
prevention and treatment of diseases in people and animals. We foster a
diverse and inclusive global workforce and operate responsibly every day
to enable a safe, sustainable and healthy future for all people and
communities.